Kyushu University Academic Staff Educational and Research Activities Database
List of Papers
Yamada Shunsuke Last modified date:2024.04.09

Assistant Professor / Department of Nephrology,Hypertension,and Strokology / Kyushu University Hospital


Papers
1. Shukuri T, Nakai K, Tanaka S, Yamada S, Tokumoto M, Tsuruya K, Nakano T, Kitazono T., Angiotensin II receptor blockers and bone fracture in chronic kidney disease patients: the Fukuoka kidney disease Registry Study, Clinical and Experimental Nephrology, 2023.11.
2. Haruyama N, Nakayama M, Yamada S, Tanaka S, Hiyamuta H, Taniguchi M, Tokumoto M, Tsuruya K, Kitazono T, Nakano T., History of fragility fracture is associated with cardiovascular mortality in hemodialysis patients: the Q-Cohort study, Journal of Bone and Mineral Metabolism, 42, 2, 253-263, 2024.05.
3. Yamada S, Arase H, Taniguchi M, Kitazono T, Nakano T., A simple score for malnutrition-inflammation complex syndrome (MICS) is associated with the risk of mortality in Japanese patients undergoing maintenance hemodialysis, Therapeutic Apheresis and Dialysis, 28, 2, 206-217, 2024.04.
4. Aihara S, Yamada S, Matsueda S, Nagashima A, Torisu K, Kitazono T, Nakano T., Magnesium inhibits peritoneal calcification as a late-stage characteristic of encapsulating peritoneal sclerosis, Scientific Reports, 16340, 2023.09.
5. Yamada S, Tanaka S, Arase H, Hiyamuta H, Kitamura H, Tokumoto M, Mitsuiki K, Tsuruya K, Kitazono T, Nakano T., Association between prevalence of laxative use and history of bone fractures and cardiovascular diseases in patients with chronic kidney disease: the Fukuoka Kidney disease Registry (FKR) study., Clinical and Experimental Nephrology, 2023.09.
6. Kishimoto H, Nakano T, Torisu K, Tokumoto M, Uchida Y, Yamada S, Taniguchi M, Kitazono T., Indoxyl sulfate induces left ventricular hypertrophy via the AhR-FGF23-FGFR4 signaling pathway., Front Cardiovasc Med, 2023.09.
7. Shukuri T, Nakai K, Tanaka S, Yamada S, Tokumoto M, Tsuruya K, Nakano T, Kitazono T., Angiotensin II receptor blockers and bone fracture in chronic kidney disease patients: the Fukuoka kidney disease Registry Study., Clinical and Experimental Nephrology, 2023.07.
8. Hiyamuta H, Yamada S, Nakano T, Taniguchi M, Masutani K, Tsuruya K, Kitazono T., Impact of Electrocardiographic Parameters on Sudden Death in Patients Receiving Maintenance Hemodialysis: Ten-Year Outcomes of the Q-Cohort Study., J Atheroscler Thromb, 2023.09.
9. Kitamura H, Yotsueda R, Hiyamuta H, Taniguchi M, Tanaka S, Yamada S, Tsuruya K, Nakano T, Kitazono T., Serum alkaline phosphatase and infection-related mortality in hemodialysis patients: ten-year outcomes of the Q-cohort study, Clinical and Experimental Nephrology, 2022.11.
10. Yamada S, Arase H, Taniguchi M, Kitazono T, Nakano T., Simplified geriatric nutritional risk index for assessing nutritional status and stratifying mortality risk in patients receiving maintenance hemodialysis, Therapeutic Apheresis and Dialysis, 2023.04.
11. Yamada S, Tanaka S, Arase H, Hiyamuta H, Kitamura H, Tokumoto M, Mitsuiki K, Tsuruya K, Kitazono T, Nakano T., Association between prevalence of laxative use and history of bone fractures and cardiovascular diseases in patients with chronic kidney disease: the Fukuoka Kidney disease Registry (FKR) study, Clinical and Experimental Nephrology, 151-160, 2023.02.
12. Kitamura H, Yamada S, Hiyamuta H, Yotsueda R, Taniguchi M, Tokumoto M, Tsuruya K, Nakano T, Kitazono T, Serum Alkaline Phosphatase Levels and Increased Risk of Brain Hemorrhage in Hemodialysis Patients: The Q-Cohort Study, Journal of atherosclerosis and thrombosis, 2022.06.
13. Arase H, Yamada S, Torisu K, Tokumoto M, Taniguchi M, Tsuruya K, Nakano T, Kitazono T, Protective Roles of Xenotropic and Polytropic Retrovirus Receptor 1 (XPR1) in Uremic Vascular Calcification, Calcified Tissue International and Musculoskeletal Research, 2022.04.
14. Yamada S, Arase H, Yoshida H, Kitamura H, Tokumoto M, Taniguchi M, Hirakata H, Tsuruya K, Nakano T, Kitazono T, Malnutrition-inflammation complex syndrome (MICS) and bone fractures and cardiovascular events in patients undergoing hemodialysis: The Q-Cohort Study, Kidney Medicine, 4, 3, 100408, 2022.01.
15. Tsujikawa H, Yamada S, Hiyamuta H, Taniguchi M, Tsuruya K, Torisu K, Nakano T, Kitazono T, Sex differences in the 10-year survival of patients undergoing maintenance hemodialysis in the Q-Cohort Study, Scientific Reports, 12, 1, 345, 2022.01.
16. Shimamoto S, Yamada S, Hiyamuta H, Arase H, Taniguchi M, Tsuruya K, Nakano T, Kitazono T, Association of the nutritional risk index for Japanese hemodialysis patients with long-term mortality: The Q-Cohort Study, Clin Exp Nephrol, 26, 1, 59-67, 2022.01.
17. Yamada S, Tanaka S, Arase H, Hiyamuta H, Yoshizumi E, Tokumoto M, Nakano T, Tsuruya K, Kitazono T, Associations Between Surrogates of Skeletal Muscle Mass and History of Bone Fracture in Patients with Chronic Kidney Disease: The Fukuoka Kidney disease Registry (FKR) Study., Calcified Tissue International and Musculoskeletal Research, 2021.10.
18. Hiyamuta H, Yamada S, Taniguchi M, Nakano T, Tsuruya K, Kitazono T, Causes of death in patients undergoing maintenance hemodialysis in Japan: 10-year outcomes of the Q-Cohort Study, Clinical and Experimental Nephrology, 25, 10, 1121-1130, 2021.10.
19. Hiyamuta H, Yamada S, Taniguchi M, Tokumoto M, Tsuruya K, Nakano T, Kitazono T, Association of hyperphosphatemia with an increased risk of sudden death in patients on hemodialysis: Ten-year outcomes of the Q-Cohort Study., Atherosclerosis, 25-31, 2021.01.
20. Tsuneyoshi S, Matsukuma Y, Kawai Y, Hiyamuta H, Yamada S, Kitamura H, Tanaka S, Taniguchi M, Tsuruya K, Nakano T, Kitazono T, Association between geriatric nutritional risk index and stroke risk in hemodialysis patients: 10-Years outcome of the Q-Cohort study., Atherosclerosis, 30-36, 2021.04.
21. Ohnaka S, Yamada S, Tsujikawa H, Arase H, Taniguchi M, Tokumoto M, Tsuruya K, Nakano T, Kitazono T., Association of normalized protein catabolic rate (nPCR) with the risk of bone fracture in patients undergoing maintenance hemodialysis: The Q-Cohort Study., Clinical Nutrtition, 30345-30349, 2021.03.
22. Suehiro T, Tsuruya K, Yoshida H, Tsujikawa H, Yamada S, Tanaka S, Tsuchimoto A, Eriguchi M, Fujisaki K, Torisu K, Nakano T, Kitazono T, Stronger Effect of Azilsartan on Reduction of Proteinuria Compared to Candesartan in Patients with CKD: A Randomized Crossover Trial., Kidney Blood Pressure Research, 173-184, 2021.02.
23. Shimamoto S, Yamada S, Hiyamuta H, Taniguchi M, Tokumoto M, Tsuruya K, Nakano T, Kitazono T, Association of serum phosphate concentration with the incidence of intervention for peripheral artery disease in patients undergoing hemodialysis. 10-years outcome of the Q Cohort Study., Atherosclerosis, 2020.06.
24. Arase H, Yamada S, Tanaka S, Tokumoto M, Tsuruya K, Nakano T, Kitazono T, Association between plasma intact parathyroid hormone level and the prevalence of atrial fibrillation in patients with chronic kidney disease: The Fukuoka Kidney Disease Registry Study., Circulation Journal, 2020.06.
25. Yamada S, Arase H, Tokumoto M, Taniguchi M, Yoshida H, Nakano T, Tsuruya K, Kitazono T, Increased risk of infection-related death in hypercalcemic patients receiving hemodialysis: The Q-Cohort Study, Scientific Reports, 2020.04.
26. Yamada S, Yamamoto S, Fukuma S, Nakano T, Tsuruya K, Inaba M, Geriatric Nutritional Risk Index (GNRI) and Creatinine Index Equally Predict the Risk of Mortality in Hemodialysis Patients: J-DOPPS, Scientific Reports, 2020.04.
27. Aihara S, Yamada S, Shichijo S, Fukumitsu K, Kondo M, Hirashima Y, Oka H, Kamimura T, Harada A, Tsuruya K, Nakano T, Kitazono T, Lidocaine-Propitocain Cream, a Eutectic Mixture of Local Anesthetics, Effectively Relieves Pain Associated with Vascular Access Intervention Therapy in Patients Undergoing Hemodialysis: A Placebo-Controlled, Double-Blind, Crossover Study, Therapeutic Apheresis and Dialysis, 2020.02.
28. Yamada S, Kawai Y, Tsuneyoshi S, Tsujikawa H, Arase H, Yoshida H, Tsuruya K, Nakano T, Kitazono T, Lower serum albumin is associated with increased risk for loss of residual kidney function in patients receiving peritoneal dialysis, Therapeutic Apheresis and Dialysis, 2020.02.
29. Nakagawa K, Yamada S, Matsukuma Y, Nakano T, Mitsuiki K, Survival comparison between superficialization of the brachial artery and tunneled central venous catheter placement in hemodialysis patients with heart failure: A retrospective study., Therapeutic Apheresis and Dialysis, 2020.02.
30. Arase H, Yamada S, Hiyamuta H, Taniguchi M, Tokumoto M, Tsuruya K, Nakano T, Kitazono T, Modified creatinine index and risk for long-term infection-related mortality in hemodialysis patients: ten-year outcomes of the Q-Cohort Study., Scientific Reports, 2020.01.
31. Sakoh T, Taniguchi M, Yamada S, Ohnaka S, Arase H, Tokumoto M, Yanagida T, Mitsuiki K, Hirakata H, Nakano T, Kitazono T, Tsuruya K., Short- and Long-term Effects of Dialysate Calcium Concentrations on Mineral and Bone Metabolism in Hemodialysis Patients: The K4 Study., Kidney Medicine, 296-306, 2019.09.
32. Oka H, Yamada S, Kamimura T, hara A, Tsuruya K, Nakano T, Kitazono T, Early Postoperative change in serum creatinine predicts acute kidney injury after cardiothoracic surgery: a retrospective cohort study., Clinical and Experimental Nephrology, 2019.06.
33. Aihara S, Yamada S, Oka H, Kamimura T, Nakano T, Tsuruya K, Harada A, Hypercalcemia and acute kidney injury induced by eldecalcitol in patients with osteoporosis: a case series of 32 patients at a single facility., Renal Failure, 2019.06.
34. Oka H, Yamada S, Kamimura T, Aihara S, Hyodo M, Terakado N, Harada A, Nakano T, Tsuruya K, and Kitazono T, Better oral hygiene habits are associated with a lower incidence of peritoneal dialysis-related peritonitis., Therapeutic Apheresis and Dialysis, 2019.04.
35. Yamada S, Wallingford MC, Borgeia S, Cox TC, Giachelli CM, Loss of PiT-2 results in abnormal bone development and decreased bone mineral density and length in mice., Biochem Biophys Res Commun, 2018.01.
36. Yamada S, Ueki K, Tokumoto M, Suehiro T, Kimura H, Taniguchi M, Fujimi S, Kitazono T, Tsuruya K., Effects of lowering dialysate calcium concentration on mineral and
bone disorders in chronic hemodialysis patients., Therapeutic Apheresis and Dialysis, 2016.06.
37. Yamada S, Tsuruya K, Taniguchi M, Tokumoto M, Fujisaki K, Hirakata H, Fujimi S, Kitazono T., Association between serum phosphate levels and stroke risk in patients undergoing hemodialysis: The Q-Cohort Study., Stroke, 2016.06.
38. Yamada S, Tsuruya K, Yoshida H, Tokumoto M, Ooboshi H, Kitazono T, Factors associated with serum myostatin level in patients undergoing peritoneal dialysis; the impact of vitamin D receptor activators use., Calcified Tissue International, 2016.06.
39. Yamada S, Tokumoto M, Tatsumoto N, Tsuruya K, Kitazono T, Ooboshi H, Fetuin-A decrease induced by a low protein diet enhances vascular calcification in uremic rats with hyperphosphatemia., American Journal of Physiology Renal Physiology, 2015.06.
40. Yamada S, Tatsumoto N, Tokumoto M, Noguchi H, Ooboshi H, Kitazono T, Tsuruya K, Phosphate binders prevent phosphate-induced cellular senescence of vascular smooth muscle cells and vascular calcification in a modified, adenine-based uremic rat model, American Journal of Physiology Renal Physiology, 2015.06.
41. Yamada S, Tsuruya K, Tokumoto M, Yoshida H, Ooboshi H, Kitazono T, Factors associated with serum soluble inhibitors of Wnt-β-catenin signaling (sclerostin and dickkopf-1) in patients undergoing peritoneal dialysis., Nephrology (Carlton), 2015.06.
42. Tatsumoto N, Yamada S, Tokumoto M, Eriguchi M, Noguchi H, Torisu K, Tsuruya K, Kitazono T., Spironolactone ameliorates arterial medial calcification in uremic rats: the role of mineralocorticoid receptor signaling in vascular calcification, American Journal of Physiology Renal Physiology, 2015.06.
43. Yamada S, Tsuruya K, Tokumoto M, Yoshida H, Hasegawa S, Tanaka S, Eriguchi M, Nakano T, Masutani K, Ooboshi H, Kitazono T, Fibroblast growth factor 23, but not parathyroid hormone, is associated with urinary phosphate regulation in patients on peritoneal dialysis with residual renal function., Therapeutic Apheresis and Dialysis, 2015.02.
44. Yamada S, Tsuruya K, Taniguchi M, Tsuruya K, Hasegawa S, Tanaka S, Eriguchi M, Nakano T, Kitazono T, Relationship between residual renal function on serum fibroblast growth factor 23 in patients on peritoneal dialysis., Therapeutic Apheresis and Dialysis, 2014.10.
45. Yamada S, Tokumoto M, Tatsumoto N, Taniguchi M, Noguchi H, Nakano T, Masutani K, Ooboshi H, Tsuruya K, Kitazono T, Phosphate overload induces systemic inflammation and malnutrition as well as vascular calcification in uremia., American Journal of Physiology Renal Physiology, 2014.06.
46. Yamada S, Tsuruya K, Yoshida H, Taniguchi M, Haruyama N, Tanaka S, Eriguchi M, Nakano T, Kitazono T, The clinical utility of serum tartrate-resistant acid phosphatase in the assessment of bone resorption in patients on peritoneal dialysis., Clinical Endocrinology, 2013.06.
47. Yamada S, Yoshida H, Tsuruya K, Haruyama N, Tanaka S, Eriguchi M, Nakano T, Taniguchi M, Tsuruya K, Kitazono T, Efficacy of lanthanum carbonate treatment in combination with other phosphate binders in peritoneal dialysis patients, Internal Medicine, 2097-2104, 2012.08.
48. Yamada S, Taniguchi M, Tokumoto M, Toyonaga J, Fujisaki K, Suehiro T, Noguchi H, Iida M, Tsuruya K, Kitazono T, The antioxidant tempol ameliorates arterial medial calcification in uremic rats: important role of oxidative stress in the pathogenesis of vascular calcification in chronic kidney disease., Journal of Bone and Mineral Research, 2012.06.
49. Yamada S, Taniguchi M, Tokumoto M, Tsuruya K, Hirakata H, Iida M, Early intervention with intravenous or pulse oral vitamin D therapy is more effective in the treatment of secondary hyperparathyroidism., Therapeutic Apheresis and Dialysis, 424-431, 2010.08.